Publications by authors named "John-Mark Fitzpatrick"

Claim this Profile
C
Cannflavin A inhibits TLR4-induced chemokine and cytokine expression in human macrophages.
John-Mark K Fitzpatrick, Diarmuid O'Riordan, Eric J Downer

Nat Prod Res· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Botanically-Derived Δ-Tetrahydrocannabinol and Cannabidiol, and Their 1:1 Combination, Modulate Toll-like Receptor 3 and 4 Signalling in Immune Cells from People with Multiple Sclerosis.
John-Mark Fitzpatrick, Becky Hackett, Lisa Costelloe, William Hind, Eric J Downer

Molecules· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phytocannabinoid-dependent mTORC1 regulation is dependent upon inositol polyphosphate multikinase activity.
Joseph L Damstra-Oddy, Eleanor C Warren, Christopher J Perry, Yann Desfougères, John-Mark K Fitzpatrick

Br J Pharmacol· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MyD88-dependent and -independent signalling via TLR3 and TLR4 are differentially modulated by Δ-tetrahydrocannabinol and cannabidiol in human macrophages.
John-Mark Fitzpatrick, Eleanor Minogue, Lucy Curham, Harry Tyrrell, Philip Gavigan

J Neuroimmunol· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Toll-like receptor signalling as a cannabinoid target in Multiple Sclerosis.
John-Mark K Fitzpatrick, Eric J Downer

Neuropharmacology· February 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MicroRNA: Key regulators of oligodendrocyte development and pathobiology.
John-Mark K Fitzpatrick, Rebecca C Anderson, Kieran W McDermott

Int J Biochem Cell Biol· August 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Modulation of TLR3/TLR4 inflammatory signaling by the GABAB receptor agonist baclofen in glia and immune cells: relevance to therapeutic effects in multiple sclerosis.
Tadhg Crowley, John-Mark Fitzpatrick, Teun Kuijper, John F Cryan, Orna O'Toole

Front Cell Neurosci· August 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis